Healthcare - Biotechnology - NASDAQ - US
$ 0.68
8.59 %
$ 3.94 M
Market Cap
-0.11
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
25.99%
Net Income
Estimate
8.76%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Hepion Pharmaceuticals, Inc.
HEPA has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart HEPA
EBIT FORECAST
EBIT Forecast Chart HEPA
NET INCOME FORECAST
Net Income Chart HEPA